about   CII home   shop   checkout

The Evidence-Based Reimbursement Summit

Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!

Register by October 24 & SAVE up to $200!   

Stratified genomic medicine, genome-guided prevention and treatment of complex diseases, is becoming a reality due to the latest achievements in genome research as well as the clinical implementation of powerful technologies such as massively parallel sequencing and digital PCR. The bottleneck of this innovation coming into clinical practice is the current reimbursement uncertainty. The combination of tightening health care budgets and the launch of a large number of expensive molecular tests as well as pricey targeted therapies creates complications for payers to respond in traditional ways. The Third Annual Evidence-Based Reimbursement Summit is designed to bring together major stakeholders from pharmaceutical, biotech, IVD companies, laboratory medicine community and healthcare providers community to exchange opinions and to search for solutions in the innovative medicine commercialization equation.

Health Economics of Personalized Genomic Medicine Banner 

View Agenda

Conference Highlights 

  • Generating Evidence For Reimbursement Decisions In Personalized Genomic Medicine
  • Supporting Pharmaceutical Innovation 
  • Value-Based Pricing In Stratifies Medicine 
  • Tools for Generating and Synthesizing Evidence 
  • Learning Healthcare System 
  • Changing Reimbursement Environment 

Featured Speakers 

Roy-BaynesRoy Baynes, M.D., Senior Vice President Global Clinical Development at Merck

Dane DicksonDane Dickson, M.D., Director, Clinical Science-MolDx, Palmetto GBA


 Evidence-Based Reimbursement of Molecular Diagnostics Banner 

View Agenda 

Conference Highlights 

  • Generating Evidence For Reimbursement Decisions in Molecular Diagnostics
  • Demystifying CMS Perspective (PAMA 2014 and More)
  • Case Studies Of Success
  • Medical Affairs At Work
  • Laboratories’ Perspective
  • Reimbursement of Stand-Alone vs Companion Molecular Tests

Featured Speakers 

Bruce QuinnBruce Quinn, M.D., Ph.D., Senior Health Policy Specialist, Foley Hoag, LLP

Robert McDonoughRobert McDonough, Head of Clinical Policy Research & Development at Aetna



Reimbursement and Adoption of Personalized Genomic Medicine
with Gregory Hess, M.D., Senior Fellow, LDI Health Economics & Policy, University of Pennsylvania 


Impact of Protecting Access to Medicare Act (PAMA) on the Molecular Diagnostics Market Environment
with John Warren, Senior Director, Health Policy, McDermott Will & Emery 

Download Conference & Course Catalog

CHI Catalog March 2018 - August 2018 Cover

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag